Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$191.51 - $216.16 $481,647 - $543,642
2,515 Added 19.79%
15,225 $3.23 Million
Q2 2023

Aug 04, 2023

BUY
$187.64 - $206.25 $118,213 - $129,937
630 Added 5.22%
12,710 $2.45 Million
Q1 2023

May 12, 2023

BUY
$127.59 - $203.08 $2,551 - $4,061
20 Added 0.17%
12,080 $2.45 Million
Q4 2022

Feb 10, 2023

SELL
$117.37 - $139.17 $163,379 - $193,724
-1,392 Reduced 10.35%
12,060 $1.55 Million
Q3 2022

Nov 14, 2022

BUY
$135.27 - $180.11 $11,227 - $14,949
83 Added 0.62%
13,452 $1.84 Million
Q2 2022

Aug 12, 2022

SELL
$108.81 - $179.33 $26,658 - $43,935
-245 Reduced 1.8%
13,369 $2.37 Million
Q1 2022

May 13, 2022

SELL
$119.61 - $157.85 $69,493 - $91,710
-581 Reduced 4.09%
13,614 $1.96 Million
Q4 2021

Feb 11, 2022

BUY
$142.57 - $190.86 $42,771 - $57,258
300 Added 2.16%
14,195 $2.2 Million
Q3 2021

Nov 12, 2021

SELL
$142.45 - $169.82 $27,207 - $32,435
-191 Reduced 1.36%
13,895 $2.36 Million
Q2 2021

Aug 13, 2021

SELL
$135.08 - $161.1 $16,885 - $20,137
-125 Reduced 0.88%
14,086 $2.22 Million
Q1 2021

May 07, 2021

SELL
$137.51 - $190.8 $90,344 - $125,355
-657 Reduced 4.42%
14,211 $1.97 Million
Q4 2020

Feb 12, 2021

BUY
$164.63 - $211.93 $2.45 Million - $3.15 Million
14,868 New
14,868 $2.6 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.